```html

Xerophytic Dermatitis

Overview

Xerophytic dermatitis (also called “dry‑skin dermatitis” or “xerotic eczema”) is a chronic inflammatory skin condition characterized by extreme dryness, scaling, and itching. It typically appears on the extremities—especially the lower legs, forearms, and hands—but can affect any part of the body.

The disorder is most common in older adults because skin naturally loses moisture and lipid content with age. However, children and younger adults with genetic predispositions, certain chronic illnesses, or prolonged exposure to harsh environments can also develop xerophytic dermatitis.

Prevalence: Epidemiological data are limited, but studies estimate that up to 15–20 % of adults over 65 experience clinically significant xerotic eczema at some point in their lives (Mayo Clinic, 2022). In the general population, mild dry‑skin conditions affect roughly 30 % of people, though only a fraction progresses to true xerophytic dermatitis.

Symptoms

Symptoms may range from mild irritation to severe, painful inflammation. Common features include:

• Dry, scaly patches – thin, silvery or white scales that can crack.
• Intense pruritus (itching) – often worse at night, leading to sleep disturbance.
• Redness (erythema) – usually localized around the edges of the dry patches.
• Fissures or cracks – particularly on the heels, elbows, and knuckles; these can bleed.
• Exacerbated itching after bathing – due to rapid loss of residual moisture.
• Thickened, leathery skin (lichenification) – from chronic scratching.
• Secondary bacterial infection – indicated by warmth, pus, or increasing pain.
• Discomfort with temperature extremes – cold, dry air worsens symptoms; heat can trigger sweating and itching.

Causes and Risk Factors

Primary causes

• Age‑related decline in skin barrier function: Reduced production of natural moisturizing factors (NMFs) and ceramides.
• Genetic predisposition: Mutations in filaggrin (FLG) gene associated with impaired barrier integrity.
• Environmental factors: Low humidity, excessive heating, wind, and sun exposure strip moisture.
• Chronic skin conditions: Atopic dermatitis, psoriasis, or ichthyosis can evolve into xerophytic dermatitis.
• Systemic diseases: Diabetes, hypothyroidism, chronic kidney disease, and certain malignancies affect skin hydration.
• Medications: Long‑term use of diuretics, retinoids, or systemic steroids can dry the skin.

Risk factors

• Age ≥ 60 years
• Family history of eczema or filaggrin mutation
• Living in arid climates or high‑altitude regions
• Occupations with frequent hand‑washing or exposure to solvents (healthcare, cleaning, hairdressing)
• Underlying medical conditions (diabetes, hypothyroidism, malnutrition)
• Smoking and excessive alcohol intake

Diagnosis

Diagnosing xerophytic dermatitis is primarily clinical, based on history and physical examination. The following steps are typical:

1. Detailed medical history

• Onset and progression of dryness and itching
• Exposures to irritants, climate, or new products
• Personal or family history of eczema, psoriasis, or other skin disorders
• Review of systemic diseases and medications

2. Physical examination

• Inspection for characteristic scaling, fissures, and erythema
• Assessment of distribution (usually symmetric on extensor surfaces)
• Palpation for skin thickness and tenderness

3. Ancillary tests (when needed)

• Skin scrapings or swabs: To rule out fungal infection (tinea) or bacterial colonization.
• Patch testing: If contact dermatitis is suspected as a trigger.
• Blood work: CBC, fasting glucose, thyroid panel, and renal function to identify systemic contributors.
• Skin biopsy: Rarely required; performed when the presentation is atypical or to exclude psoriasis, cutaneous lymphoma, or drug reactions.

Treatment Options

Treatment aims to restore the skin barrier, relieve itching, and address any underlying disease.

1. Skin‑care regimen (first‑line)

• Gentle, fragrance‑free cleansers: Avoid alkaline soaps; use syndet bars or non‑soap cleansers.
• Moisturizers (emollients): Apply within 3 minutes of bathing while skin is still damp. Preferred options:
  • Petrolatum‑based ointments (e.g., Vaseline)
  • Ceramide‑rich creams (e.g., CeraVe, Eucerin)
  • Urea‑containing lotions (10‑20 %) for thick scaling
• Humidifier use: Maintain indoor humidity at 40‑60 % during winter.

2. Pharmacologic therapy

• Topical corticosteroids: Low‑ to mid‑potency (hydrocortisone 1 % or triamcinolone 0.1 %) for flare‑ups; limit use to ≤2 weeks to avoid skin thinning.
• Topical calcineurin inhibitors (TCIs): Tacrolimus ointment 0.03 % or pimecrolimus cream 1 % for sensitive areas (face, neck) where steroids are risky.
• Topical phosphodiesterase‑4 inhibitor: Crisaborole 2 % ointment—effective for mild‑moderate eczema and suitable for xerophytic dermatitis.
• Systemic agents (reserved for severe or refractory cases):
  • Oral antihistamines (cetirizine, fexofenadine) for itch control.
  • Short courses of oral corticosteroids (prednisone ≤10 mg/day, ≤2 weeks) for acute severe inflammation.
  • Dupilumab (IL‑4Rα antagonist) – approved for moderate‑to‑severe atopic dermatitis; off‑label use reported in persistent xerotic eczema.

3. Procedure‑based options

• Phototherapy (narrow‑band UVB): May improve barrier function in refractory cases.
• Wet‑wrap therapy: Applying a moisturizer followed by a damp layer and dry bandage for 12–24 hours to enhance penetration.

4. Addressing underlying disease

Optimizing control of diabetes, hypothyroidism, or renal disease often reduces xerosis severity.

Living with Xerophytic Dermatitis

Daily skin‑care routine

1. Morning: Cleanse with lukewarm water and a mild cleanser; pat skin dry; apply a ceramide‑rich moisturizer.
2. Mid‑day: Re‑apply a thin layer of moisturizer if skin feels tight.
3. Evening: Take a short (5‑10 min) lukewarm shower; use a gentle cleanser; immediately moisturize with an ointment.

Practical tips

• Wear soft, breathable fabrics (cotton, bamboo); avoid wool or synthetic fibers that can irritate.
• Protect hands with cotton gloves when using cleaning agents or dish soap.
• Limit hot showers and baths; water >38 °C strips natural oils.
• Stay hydrated—aim for ≥2 L of water daily.
• Use sunscreen (SPF 30+) on exposed areas; some sunscreen formulas dry the skin, so choose moisturising, fragrance‑free options.
• Keep nails trimmed to reduce skin damage from scratching.
• Maintain a regular sleep schedule; poor sleep can worsen itch perception.

Prevention

While not all cases are preventable, the following strategies markedly lower risk:

• Use a humidifier in heated indoor environments.
• Adopt a consistent moisturizing routine—apply emollient at least twice daily.
• Avoid skin‑irritating products: fragrances, alcohol‑based toners, harsh detergents.
• Practice gentle hand‑washing (lukewarm water, mild soap, immediate moisturization).
• Control systemic conditions (diabetes, thyroid disease) through regular medical follow‑up.
• Wear protective clothing (gloves, long sleeves) when working outdoors in windy or cold climates.
• Limit exposure to cigarette smoke and excessive alcohol, both of which impair skin barrier repair.

Complications

If left inadequately treated, xerophytic dermatitis can lead to:

• Secondary infections: Bacterial (Staphylococcus aureus, Streptococcus) or fungal (Candida, dermatophytes) infections requiring antibiotics or antifungals.
• Chronic pain and reduced mobility: Deep fissures on feet or hands can impair walking or manual tasks.
• Psychological impact: Persistent itching and visible lesions are linked to anxiety, depression, and decreased quality of life (JAMA Dermatol, 2021).
• Skin thickening (lichenification): Permanent changes that may be difficult to reverse.
• Scarring: Deep cracks that heal with fibrotic tissue.

When to Seek Emergency Care

References

• Mayo Clinic. “Dry skin (xerosis) and eczema.” Updated 2022.
• Centers for Disease Control and Prevention (CDC). “Skin health and hygiene.” 2023.
• National Institutes of Health (NIH) – National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Eczema.” 2021.
• World Health Organization (WHO). “Guidelines for the management of chronic skin diseases.” 2020.
• Cleveland Clinic. “Managing Dry Skin and Eczema.” 2024.
• JAMA Dermatology. “Psychosocial burden of chronic pruritic skin diseases.” 2021.
• British Journal of Dermatology. “Filaggrin deficiency and xerotic eczema.” 2022.

```